Skip to main content

Cancer Screening? There’s an ARK ETF for That

Cancer therapies and treatments are among the biggest markets in the broader biotechnology sector, and genomics is one of the preferred avenues for that exposure. Enter the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Cancer screening is among the many rapidly evolving genomics frontiers...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.